TABLE 1.

Patient’s demographic and clinical characteristics in the two study groups depicted as percentages of respective categories or mean ± standard deviation (LC and HCC).

Variable	LC	HCC	p-Value
Age > 60 years	36.84%	68.75%	0.003
Male	55.26%	56.25%	0.92
HVC etiology	38.89%	52.08%	0.23
HBV etiology	33.33%	33.33%	1
HDV etiology	25%	8.33%	0.07
INR	1.5 ± 0.49	1.12 ± 0.18	<0.0001
Tbil (mg/dl)	2.99 ± 3.13	0.83 ± 0.58	<0.0001
Serum creatinine (mg/dl)	0.88 ± 0.24	0.97 ± 0.31	0.29
Serum albumin (g/dl)	3.34 ± 0.79	3.67 ± 0.72	0.06
MELD score	14.02 ± 5.09	8.83 ± 2.83	<0.0001
Ascites	31.11%	6.25%	0.001
Child Pugh class A	52.63%	91.67%
Child Pugh class B	28.95%	8.33%
Child Pugh class C	18.42%	0%	0.0001
Serum AFP (ng/ml)	10.52 ± 18.15	200.55 ± 380.29	0.001
miR-21-5p relative expression	15.17 ± 19.29	47.96 ± 71.31	0.017
miR-92a-3p relative expression	1.24 ± 1.18	0.61 ± 0.99	0.0005

HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis D virus; INR, international normalized ratio; Tbil, total bilirubin; MELD score, model for end-stage liver disease score; AFP, alpha-fetoprotein.